Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-021574
Filing Date
2012-04-13
Accepted
2012-04-13 17:24:53
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v306928_10k.htm 10-K 1507178
2 EXHIBIT 23.1 v306928_ex23-1.htm EX-23.1 3478
3 EXHIBIT 31.1 v306928_ex31-1.htm EX-31.1 10659
4 EXHIBIT 32.1 v306928_ex32-1.htm EX-32.1 4897
5 GRAPHIC pg4.jpg GRAPHIC 111159
6 GRAPHIC pg6.jpg GRAPHIC 94730
7 GRAPHIC pg9a.jpg GRAPHIC 43151
8 GRAPHIC pg9b.jpg GRAPHIC 43990
  Complete submission text file 0001144204-12-021574.txt   5587874

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT nwboob-20111231.xml EX-101.INS 870973
10 XBRL TAXONOMY EXTENSION SCHEMA nwboob-20111231.xsd EX-101.SCH 37064
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwboob-20111231_cal.xml EX-101.CAL 35816
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwboob-20111231_def.xml EX-101.DEF 131143
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwboob-20111231_lab.xml EX-101.LAB 300869
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwboob-20111231_pre.xml EX-101.PRE 163444
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33393 | Film No.: 12759408
SIC: 2834 Pharmaceutical Preparations